Avoid concomitant use with phenobarbital.
Source: NLP:phenobarbital sodium
7 interactions on record
Avoid concomitant use with phenobarbital.
Source: NLP:phenobarbital sodium
Potential pharmacodynamic interaction with QT-prolonging neuroleptics; may precipitate arrhythmias.
Source: NLP:droperidol
Concomitant use may result in greater QTc interval prolongation and serious adverse reactions including torsade de pointes, other serious arrhythmias, and sudden death.
Source: NLP:haloperidol decanoate
QT interval prolongation and ventricular arrhythmias can occur with coadministration. Avoid coadministration of oxaliplatin with medicinal products with known potential to prolong QT interval.
Source: NLP:oxaliplatin
Avoid concomitant use. If unavoidable, obtain ECGs and monitor for QTc prolongation. Ziftomenib causes QTc prolongation; concomitant use may result in serious arrhythmias and sudden death.
Source: NLP:ziftomenib
Electrolyte imbalances from mannitol may result in cardiac adverse reactions; monitor serum electrolytes.
Source: NLP:mannitol
Use olanzapine and fluoxetine capsules with caution in combination with other QT-prolonging drugs.
Source: NLP:olanzapine and fluoxetine